Related Experiment Video
Updated: Jan 20, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Structural insight into conformational dynamics of non-active site mutations in KasA: A Mycobacterium tuberculosis
Manikandan Jayaraman1, Savita Kumari Rajendra1, Krishna Ramadas1
1Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry 605014, India.
Abstract:
The enzyme β-Ketoacyl ACP synthase I (KasA) is a potent drug target in mycolic acid pathway of Mycobacterium tuberculosis (Mtb). In the present study, we investigated the structural dynamics of wild-type (WT) and mutants KasA (D66N, G269S, G312S, and F413L) in both monomer and dimer form to provide insight into protein structural stability. To gain better understanding of structural flexibility of KasA, combined molecular dynamics and essential dynamics were employed to analyze the conformational changes induced by non-active site mutations. The results confirm that non-active site mutations lower the structural stability in dimer KasA as compared to WT. The protein network topology and close residue interactions of WT and mutant residues of KasA have been predicted through residue interaction network analysis (RIN). Non-active site mutations distort RIN architecture and subsequently affect the drug binding landscape. T-pad associated with mode vector analysis comprehensively pronounces the structural impact caused by non-active site mutations. It also identified the critical fluctuating residues present in the gate segment (GS) region (115-147). The non-active site mutations altered the structural stability of the mutant protein structures, and these mutations may be a cause for the resistance mechanism of KasA against anti-tuberculosis drugs. Further, it is observed that dimer mutant KasA proteins display much more structural flexibility than WT at the ligand binding site which is evident from the binding site analysis and hydrogen bond interaction patterns. This study provides a better understanding of the structural dynamic behaviour of KasA mutants, thereby facilitating the need to find a novel and potent inhibitor against Mtb.
Insights
Non-active site mutations in KasA (β-Ketoacyl ACP synthase I) reduce structural stability and alter drug binding, potentially explaining resistance to anti-tuberculosis drugs.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Mycobacterium tuberculosis (Mtb) relies on the mycolic acid pathway, with β-Ketoacyl ACP synthase I (KasA) as a key drug target.
- Understanding KasA's structural dynamics is crucial for developing effective anti-tuberculosis therapies.
Purpose of the Study:
- Investigate the structural dynamics and stability of wild-type (WT) and mutant KasA proteins (D66N, G269S, G312S, F413L).
- Analyze the impact of non-active site mutations on KasA's conformational changes, protein network topology, and drug binding landscape.
Main Methods:
- Employed combined molecular dynamics and essential dynamics to study KasA's structural flexibility.
- Utilized residue interaction network (RIN) analysis and T-pad mode vector analysis to assess structural impacts.
- Performed binding site analysis and hydrogen bond interaction pattern evaluation.
Main Results:
- Non-active site mutations decrease structural stability in dimer KasA compared to WT.
- Mutations distort RIN architecture, affecting the drug binding landscape and identifying critical residues in the gate segment.
- Dimer mutant KasA proteins exhibit increased flexibility at the ligand binding site.
Conclusions:
- Non-active site mutations in KasA alter structural stability and flexibility, potentially contributing to drug resistance in Mtb.
- Findings provide insights into KasA's dynamic behavior, aiding the development of novel anti-tuberculosis inhibitors.
More Related Videos
08:48Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
Published on: July 11, 2025
06:14Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis
Published on: September 26, 2025
Related Concept Videos
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
08:48Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
06:14Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis
10:06Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1